These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32928731)

  • 1.
    Santos CC; Zhang H; Batista MM; de Oliveira GM; Demarque KC; da Silva-Gomes NL; Moreira OC; Ogungbe IV; Soeiro MNC
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32928731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
    Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD
    Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Antileishmanial Activity of Thioridazine.
    Sifontes-Rodríguez S; Mollineda-Diogo N; Monzote-Fidalgo L; Escalona-Montaño AR; Escario García-Trevijano JA; Aguirre-García MM; Meneses-Marcel A
    Acta Parasitol; 2024 Mar; 69(1):324-331. PubMed ID: 38070122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B.
    Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis.
    Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL
    PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semicarbazone derivatives as promising therapeutic alternatives in leishmaniasis.
    Cavalcanti de Queiroz A; Alves MA; Barreiro EJ; Lima LM; Alexandre-Moreira MS
    Exp Parasitol; 2019 Jun; 201():57-66. PubMed ID: 31004571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
    Coelho AC; Trinconi CT; Costa CH; Uliana SR
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2999. PubMed ID: 25033218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
    Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
    Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria-dependent pathway cell death.
    Granato JDT; Silva ETD; Lemos ASO; Machado PA; Midlej VDV; Antinarelli LMR; Silva Neto AFD; Souza MVN; Coimbra ES
    Chem Biol Drug Des; 2024 May; 103(5):e14535. PubMed ID: 38772877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cinnamaldehyde on Leishmania (Leishmania) amazonensis.
    Ávila Brustolin A; Fernandes Herculano Ramos-Milaré ÁC; Perles de Mello TF; Alessi Aristides SM; Campana Lonardoni MV; Verzignassi Silveira TG
    Exp Parasitol; 2022; 236-237():108244. PubMed ID: 35259404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic investigation of 4-nitrophenylacetyl- and 4-nitro-1
    Santos CC; Zhang H; Batista MM; de Oliveira GM; Demarque KC; da Silva NL; Moreira OC; Ogungbe IV; Soeiro MNC
    Parasitology; 2022 Apr; 149(4):490-495. PubMed ID: 35109958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of physalins purified from Physalis angulata in in vitro and in vivo models of cutaneous leishmaniasis.
    Guimarães ET; Lima MS; Santos LA; Ribeiro IM; Tomassini TB; Ribeiro dos Santos R; dos Santos WL; Soares MB
    J Antimicrob Chemother; 2009 Jul; 64(1):84-7. PubMed ID: 19454526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis.
    Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA
    Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.
    Ferreira BA; Coser EM; de la Roca S; Aoki JI; Branco N; Soares GHC; Lima MIS; Coelho AC
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparasitic Activity of Two Natural Terpenes from
    Troncoso ME; Germanó MJ; Arrieta VJ; García Bustos MF; Cifuente D; Cargnelutti DE; Lozano ES
    J Nat Prod; 2023 Apr; 86(4):797-803. PubMed ID: 36857574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis.
    da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC
    J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.